Estados financieros detallados de Quoin Pharmaceuticals, Ltd. (QNRX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $6.90, QNRX presenta beneficios negativos (P/E no significativo) y un ROE del -304.87%. La capitalización bursátil es de $14M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | -$280000 | 0 | -$280000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $89130 | $104223 | $125720 | $227055 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$369130 | -$104223 | -$405720 | -$227055 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $8.3M | $5.9M | $8.3M | $45650 | $244155 | $1.6M | $2.7M | $3.3M | $3.6M | $9.8M |
| Generales y Administrativos | $8.0M | $4.2M | $8.0M | $1.5M | $1.4M | $4.5M | $6.6M | $6.1M | $5.9M | $6.5M |
| Gastos Operativos | $16.2M | $10.1M | $16.2M | $1.6M | $1.7M | $6.1M | $9.3M | $9.4M | $9.5M | $16.3M |
| Beneficio Operativo | $15.3M | $10.2M | $15.3M | -$1.6M | -$1.7M | -$6.1M | -$9.3M | -$9.4M | -$9.5M | -$16.3M |
| EBITDA | -$3.9M | -$7.8M | -$5.5M | -$1.5M | -$1.6M | -$20.3M | -$8.6M | -$8.6M | -$8.9M | -$15.7M |
| Gastos por Intereses | 0 | 0 | 0 | $412292 | $1.2M | $1.1M | $714081 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $15.3M | $10.2M | $15.3M | -$1.6M | -$2.1M | -$21.5M | -$9.4M | -$8.7M | -$9.0M | -$15.8M |
| Impuestos | $147942 | -$1.2M | -$161141 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $15.3M | $10.2M | $15.3M | -$1.6M | -$2.1M | -$21.5M | -$9.4M | -$8.7M | -$9.0M | -$15.8M |
| BPA | $-160847.00 | $-257489.00 | $-158862.00 | $-16307.00 | $-1290.96 | $-2490.26 | $-11.42 | $-11781.00 | $-2352.81 | $-10.63 |
| BPA Diluido | $-160847.00 | $-257489.00 | $-158862.00 | $-16307.00 | $-1290.96 | $-2490.26 | $-11.42 | $-11781.00 | $-2352.81 | $-10.63 |
| Acciones en Circulación (Diluidas) | $24 | $30 | $35 | $289 | $1634 | $8624 | $823706 | $735 | $3827 | $1.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | -$25429 |
| Beneficio Operativo | -$4.0M | -$4.5M | -$5.1M | -$5.6M |
| EBITDA | -$3.9M | -$4.3M | -$5.1M | -$5.5M |
| Beneficio Neto | -$3.9M | -$4.3M | -$5.0M | -$5.5M |
| BPA | $-6.74 | $-2.92 | $-2.54 | $-2.72 |
| BPA Diluido | $-6.74 | $-2.92 | $-2.54 | $-2.72 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.6M | $4.0M | $4.8M | $5.2M | $323832 | $7.5M | $2.9M | $2.4M | $3.6M | $3.82B |
| Inversiones a Corto | $6.4M | $4.0M | 0 | 0 | 0 | 0 | $10.0M | $8.3M | $10.4M | $14.9M |
| Cuentas por Cobrar | $172007 | $70572 | $57804 | $77301 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $8.4M | $8.2M | $5.0M | $5.4M | $465170 | $8.2M | $13.4M | $11.3M | $14.9M | $20.0M |
| Inmovilizado Material | $356746 | $387139 | $413193 | $672553 | $1.9M | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $1.0M | $912648 | $808604 | $704561 | $583334 | $483334 | $383.3M |
| Activos Totales | $8.8M | $8.7M | $5.5M | $6.2M | $1.4M | $9.4M | $14.5M | $12.2M | $15.7M | $20.4M |
| Cuentas por Pagar | $348951 | $490549 | $237372 | $45744 | 0 | $923239 | $605600 | $526523 | $905704 | $1.3M |
| Deuda a Corto | $15070 | 0 | 0 | $114649 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $905507 | $1.2M | $1.3M | $1.1M | $8.0M | $4.6M | $3.5M | $3.6M | $4.2M | $5.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.4M | $3.3M | $1.8M | $1.9M | $8.0M | $8.7M | $7.1M | $6.5M | $6.5M | $7.3M |
| Reservas | -$9.3M | -$18.4M | -$22.5M | -$29.2M | -$6.6M | -$28.1M | -$37.5M | -$46.2M | -$55.2M | -$71.0M |
| Patrimonio Neto | $7.4M | $5.4M | $3.7M | $4.3M | -$6.6M | $657032 | $7.4M | $5.7M | $9.2M | $13.1M |
| Deuda Total | $15070 | 0 | 0 | $310654 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$8.0M | -$8.0M | -$4.8M | -$4.9M | $889481 | -$7.5M | -$12.9M | -$10.7M | -$14.1M | -$3.82B |
| Capital Circulante | $7.5M | $7.0M | $3.7M | $4.3M | -$7.5M | $3.6M | $9.8M | $7.7M | $10.7M | $14.5M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $1.8M | $3.82B | $3.1M | $3.8M |
| Activos Totales | $6.4M | $20.4M | $15.7M | $12.0M |
| Pasivos Totales | $7.6M | $7.3M | $6.9M | $8.0M |
| Patrimonio Neto | -$1.2M | $13.1M | $8.8M | $3.9M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$4.0M | -$7.9M | -$5.6M | -$4.7M | -$2.1M | -$21.5M | -$9.4M | -$8.7M | -$9.0M | -$15.9M |
| Amortizaciones | $89130 | $104223 | $125720 | $227055 | $104043 | $104043 | $104043 | $103706 | $100000 | $100000 |
| Compensación en Acciones | 0 | 0 | 0 | 0 | 0 | 0 | $764007 | $1.1M | $1.3M | $1.1M |
| Cambio en Capital Circulante | $54889 | $245709 | $233918 | -$358685 | $274355 | $632327 | -$94351 | $95201 | -$2137 | $1.2M |
| Flujo de Caja Operativo | -$3.8M | -$5.0M | -$6.6M | -$5.7M | -$1.3M | -$5.7M | -$8.5M | -$7.9M | -$7.9M | -$13.5M |
| Inversiones (CapEx) | -$330645 | -$74525 | -$182462 | -$34519 | -$125000 | -$625000 | -$250000 | $4 | 0 | $4 |
| Adquisiciones | $24831 | 0 | 0 | $1684 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | -$65.3M | 0 | 0 | 0 |
| Flujo de Caja Libre | -$4.1M | -$5.1M | -$6.8M | -$5.7M | -$1.5M | -$6.3M | -$8.7M | -$7.9M | -$7.9M | -$13.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.2M | -$5.1M | -$4.9M | -$3.2M |
| Inversiones (CapEx) | 0 | $4 | 0 | -$3 |
| Flujo de Caja Libre | -$2.2M | -$5.1M | -$4.9M | -$3.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $182188 | $1.15B | $444525 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +100.0% | | +100.0% | | | | | | |
| Crecimiento Beneficio Neto (anual) | | -33.6% | +50.6% | -110.2% | -34.3% | -924.3% | +56.3% | +7.4% | -3.2% | -76.3% |
| Crecimiento BPA (anual) | | -60.1% | +38.3% | +89.7% | +92.1% | -92.9% | +99.5% | -103061.1% | +80.0% | +99.5% |
| Cambio en Acciones (anual) | | +25.0% | +16.7% | +725.7% | +465.4% | +427.8% | +9451.3% | -99.9% | +420.7% | +39051.4% |
| Crecimiento FCF (anual) | | -23.3% | -33.7% | +15.0% | +74.5% | -333.5% | -37.6% | +9.9% | +0.1% | -72.3% |
| Margen Bruto | 131.8% | | 144.9% | | | | | | | |
| Margen Operativo | -5470.4% | | -5470.4% | | | | | | | |
| Margen EBITDA | 1394.9% | | 1953.1% | | | | | | | |
| Margen Neto | -5470.4% | | -5470.4% | | | | | | | |
| Margen FCF | 1463.4% | | 2413.0% | | | | | | | |
| Tasa Impositiva Efectiva | 1.0% | -11.5% | -1.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-170735.54 | $-168438.17 | $-193039.69 | $-19869.69 | $-895.74 | $-735.75 | $-10.60 | $-10699.90 | $-2053.12 | $-9.04 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $79.23 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $24 | $30 | $35 | $289 | $1634 | $8624 | $823706 | $735 | $3827 | $1.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -304.87% |
| Rentabilidad sobre capital invertido | -359.18% |
| Rentabilidad sobre activos | -156.71% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 1.76 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -2.02 | -2.85 | -1.39 | -2.86 | -35.14 | -3.84 | -52.22 | -0.01 | -0.01 | -1.36 |
| P/VC | 1.09 | 4.12 | 2.08 | 3.14 | -11.22 | 125.42 | 66.33 | 0.02 | 0.01 | 1.65 |
| P/V | -28.73 | 0.00 | -27.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 131.8% | 0.0% | 144.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -5470.4% | 0.0% | -5470.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -5470.4% | 0.0% | -5470.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |